Names and pronunciation
(soe′-ni-deg′-ib) Odomzo
PDF page 1227
Drug reference
(soe′-ni-deg′-ib) Odomzo
PDF page 1227
Func. class.: Antineoplastic
PDF page 1227
USES: Locally advanced basal cell carci- noma that has recurred after surgery or radiation therapy or in those who are not candidates for surgery or radiation therapy
PDF page 1227
CONTRAINDICATIONS: Hyper sensitivity
PDF page 1227
Black Box Warning: Pregnancy, intrau- terine fetal death, contraceptive require- ment
PDF page 1227
DOSAGE AND ROUTES • Adult: PO 200 mg daily until disease progression or unacceptable toxicity; take on an empty stomach ≥1 hr before or 2 hr after a meal. Avoid use with strong CYP3A inhibitors or strong and moderate CYP3A inducers
PDF page 1227
Available forms: Capsules 200 mg HIGH ALERT
PDF page 1227
• Adult: PO 200 mg daily until disease progression or unacceptable toxicity; take on an empty stomach ≥1 hr before or 2 hr after a meal. Avoid use with strong CYP3A inhibitors or strong and moderate CYP3A inducers
PDF page 1227